Stevanato Group S.p.A (STVN) Non-Current Debt (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Non-Current Debt came in at $370.9 million in Q2 2026, down 4.38% year-over-year from $387.8 million in Q2 2025, and down 2.16% quarter-over-quarter from $379.1 million in Q1 2026.
Analysis
Stevanato Group S.p.A (STVN) Non-Current Debt (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Non-Current Debt for 7 consecutive years, with $370.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 4.38% year-over-year to $370.9 million in Q2 2026; TTM through Jun 2026 was $370.9 million, a 4.38% decrease from a year earlier, with the FY2025 full-year figure at $404.4 million, up 19.11% from the prior year.
- Non-Current Debt was $370.9 million for Q2 2026 at Stevanato Group S.p.A, down from $379.1 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $430.3 million in Q3 2025 and troughed at $131.6 million in Q2 2023.
- A 5-year average of $280.1 million and a median of $289.9 million in 2023 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt slumped 41.24% in 2022 and surged 106.48% in 2024, its largest moves.
- Over 5 years, Non-Current Debt stood at $151.4 million in 2022, then surged by 81.66% to $275.1 million in 2023, then advanced by 23.42% to $339.5 million in 2024, then grew by 19.11% to $404.4 million in 2025, then slipped by 8.28% to $370.9 million in 2026.
- The last three Non-Current Debt figures came in at $370.9 million (Q2 2026), $379.1 million (Q1 2026), and $404.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 13.51 Bn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 12.55 Bn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 202.90 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 8.62 Bn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 370.86 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 22.64 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 7.24 Mn |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 336,991.00 |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 80,924.00 |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | 126,201.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 370.86 Mn |
| Mar 31, 2026 | 379.05 Mn |
| Dec 31, 2025 | 404.35 Mn |
| Sep 30, 2025 | 430.31 Mn |
| Jun 30, 2025 | 387.85 Mn |
| Mar 31, 2025 | 329.79 Mn |
| Dec 31, 2024 | 339.47 Mn |
| Sep 30, 2024 | 317.79 Mn |
| Jun 30, 2024 | 271.78 Mn |
| Mar 31, 2024 | 304.76 Mn |
| Dec 31, 2023 | 275.05 Mn |
| Sep 30, 2023 | 213.70 Mn |
| Jun 30, 2023 | 131.62 Mn |
| Mar 31, 2023 | 153.78 Mn |
| Dec 31, 2022 | 151.41 Mn |
| Sep 30, 2022 | 172.23 Mn |
| Jun 30, 2022 | 187.21 Mn |
| Mar 31, 2022 | 221.36 Mn |
| Dec 31, 2021 | 231.42 Mn |
| Sep 30, 2021 | 279.62 Mn |